IGN AB Ignitis Grupe GDR

On received court claim

On received court claim

On received court claim and adopted interim measures

AB “Ignitis grupė” (hereinafter – the Company) informs that on 4 May 2021 it received information that Vilnius District Prosecutor’s Office (hereinafter – the Prosecutor) applied to Vilnius District Court (hereinafter – the Court) with a claim related to the decisions of the Company’s General Meeting of Shareholders and Management Board in respect of employee and executive incentive with share options plans implemented by the Company and invalidation of option agreements as well as request for application of interim measures (hereinafter – IM).

IM were applied by the Court order on 3 May 2021, which, in principle, has suspended the employee stock ownership plan as well as executive long-term incentive with share options plan until the Court decision in respect of this case takes effect.

According to the assessment of the Company, employee and executive incentive with share options plans as a variable remuneration part is a modern process complying with the best international practices and Law of the Republic of Lithuania.

The Company reminds that the Company’s shares can be acquired by retail investors from Lithuania and abroad in the regulated markets. This part of the shares, which is being traded in the regulated markets, is not a state-controlled asset. Only the Company’s own shares owned by it would be allocated as part of remuneration and incentive system, which would be acquired in the regulated markets of own shares; the shares belonging to the state as per right of ownership would not be allocated and it would not affect the size of the controlling stake of the controlling shareholder – the state – in any capacity.

In the opinion of the Company, when implementing employee and executive options plans, neither the public interest, nor legal acts were violated.

We respect the Prosecutor’s right to apply to judicial authorities when conducting the functions appointed to it. The final decision on the merits of the claim will be made by the Court. The Court process will not affect the Company’s activities.

The Company will evaluate the arguments of the claim and the Court order and will make decisions on the further procedural actions.

The Company had a broader statement on the plans and their legal regulation in a

For more information please contact:

Artūras Ketlerius

Head of Public Relations at Ignitis Group





EN
04/05/2021

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on AB Ignitis Grupe GDR

 PRESS RELEASE

Notice of convening the General Meeting of Shareholders of AB “Ignitis...

Notice of convening the General Meeting of Shareholders of AB “Ignitis grupė” On 13 August 2025, the Management Board of AB “Ignitis grupė” (hereinafter – the Group or AB “Ignitis grupė”), legal entity code: 301844044, registered office address: Laisvės Ave. 10, Vilnius, decided to convene the General Meeting of Shareholders (hereinafter – GM) of the Group. The GM will be held on 10 September 2025, at 16:00 (Vilnius time) at Business Garden Vilnius verslo centras, Laisvės Ave. 10, Vilnius, LT-04215. Registration starts at 15:00 and closes at 15:45 (Vilnius time). The agenda for the GM, wh...

 PRESS RELEASE

Notice of convening the General Meeting of Shareholders of AB “Ignitis...

Notice of convening the General Meeting of Shareholders of AB “Ignitis grupė” On 13 August 2025, the Management Board of AB “Ignitis grupė” (hereinafter – the Group or AB “Ignitis grupė”), legal entity code: 301844044, registered office address: Laisvės Ave. 10, Vilnius, decided to convene the General Meeting of Shareholders (hereinafter – GM) of the Group. The GM will be held on 10 September 2025, at 16:00 (Vilnius time) at Business Garden Vilnius verslo centras, Laisvės Ave. 10, Vilnius, LT-04215. Registration starts at 15:00 and closes at 15:45 (Vilnius time). The agenda for the GM, wh...

 PRESS RELEASE

Pranešimas apie šaukiamą AB „Ignitis grupė“ visuotinį akcininkų susiri...

Pranešimas apie šaukiamą AB „Ignitis grupė“ visuotinį akcininkų susirinkimą 2025 m. rugpjūčio 13 d. AB „Ignitis grupė“ (toliau – Grupė arba AB „Ignitis grupė“), juridinio asmens kodas: 301844044, registruotos buveinės adresas: Laisvės pr. 10, Vilnius, valdyba, priėmė sprendimą sušaukti Grupės visuotinį akcininkų susirinkimą (toliau –VAS). VAS įvyks 2025 m. rugsėjo 10 d. 16:00 val. (Vilniaus laiku), Business Garden Vilnius verslo centre, Laisvės pr. 10, Vilnius, LT-04215. Akcininkų registracijos pradžia – 15:00 val. (Vilniaus laiku), akcininkų registracijos pabaiga – 15:45 val. (Vilniaus la...

 PRESS RELEASE

First six months 2025: solid results and continued strategy delivery, ...

First six months 2025: solid results and continued strategy delivery, highlighted by the launch of 313.7 MW Kelmė wind farm, the largest in the Baltics. Full-year 2025 Adjusted EBITDA and Investments guidance reiterated AB “Ignitis grupė” publishes its First six months 2025 interim report, which is attached to this notice. Financial performance Our Adjusted EBITDA for the first six months of 2025 amounted to EUR 300.8 million (+3.8% YoY). The growth was driven by the stronger performance of our two largest segments: Green Capacities and Networks. The Green Capacities segment remained the ...

 PRESS RELEASE

First six months 2025: solid results and continued strategy delivery, ...

First six months 2025: solid results and continued strategy delivery, highlighted by the launch of 313.7 MW Kelmė wind farm, the largest in the Baltics. Full-year 2025 Adjusted EBITDA and Investments guidance reiterated AB “Ignitis grupė” publishes its First six months 2025 interim report, which is attached to this notice. Financial performance Our Adjusted EBITDA for the first six months of 2025 amounted to EUR 300.8 million (+3.8% YoY). The growth was driven by the stronger performance of our two largest segments: Green Capacities and Networks. The Green Capacities segment remained the ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch